Nuvectis Pharma

(NASDAQ) NVCT

Current Price$10.96

Market Cap$290.19M

Since IPO (2022)+227%

5 YearN/A

1 Year+9%

1 Month+28%

Nuvectis Pharma Financials at a Glance

Market Cap

$290.19M

Revenue (TTM)

$0.00

Net Income (TTM)

$27.16M

EPS (TTM)

$-1.27

P/E Ratio

-8.58

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$10.96

Volume

5,057

Open

$10.78

Price

$10.96

Volume

5,057

Open

$10.78

Previous Close

$10.96

Daily Range

$10.77 - $11.06

52-Week Range

$5.55 - $13.34

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$10.96

Volume

5,057

Open

$10.78

Previous Close

$10.96

Daily Range

$10.77 - $11.06

52-Week Range

$5.55 - $13.34

NVCT News

Nuvectis (NVCT) Q2 Loss Widens 43%

Motley Fool Markets TeamAug 5, 2025

NVCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nuvectis Pharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ronald E. Bentsur, MBA

Website

www.nuvectis.com

Headquarters

Fort Lee, NJ 07024, US

NVCT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-168%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-11.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$290.19M

Shares Outstanding

26.53M

Volume

5.06K

Avg. Volume

72.29K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$27.57M

EBITDA

$27.57M

Operating Cash Flow

$16.01M

Capital Expenditure

$0.00

Free Cash Flow

$16.01M

Cash & ST Invst.

$31.63M

Total Debt

$0.00

Nuvectis Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$290.19M

N/A

Market Cap/Employee

$22.32M

N/A

Employees

N/A

Net Income

$6.05M

-13.5%

EBITDA

$6.26M

-12.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$25.13M

-15.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.07%

N/A

Return on Invested Capital

-1.99%

N/A

Free Cash Flow

$6.51M

-56.0%

Operating Cash Flow

$6.51M

-56.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CGENCompugen Ltd.

CGENCompugen Ltd.$2.61-3.51%

TNXPTonix Pharmaceuticals Holding Corp.

TNXPTonix Pharmaceuticals Holding Corp.$14.00-3.45%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.97-10.45%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$3.80+1.60%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.52+1.33%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.79-2.72%

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$1.07-1.83%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NIONio

NIONio$5.60+0.00%

QBTSD-Wave Quantum

QBTSD-Wave Quantum$25.74+0.33%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.72+0.00%

NOKNokia

NOKNokia$14.18+0.04%

FFord Motor Company

FFord Motor Company$13.66+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.95+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.96-0.01%

Questions About NVCT

What is the current price of Nuvectis Pharma?

Nuvectis Pharma is trading at $10.96 per share.

What is the 52-week range for Nuvectis Pharma?

Over the past 52 weeks, Nuvectis Pharma has traded between $5.55 and $13.34.

How much debt does Nuvectis Pharma have?

As of the most recent reporting period, Nuvectis Pharma reported total debt of N/A.

How much cash does Nuvectis Pharma have on hand?

Nuvectis Pharma reported $25.13M in cash and cash equivalents in its most recent financial results.

What is Nuvectis Pharma’s dividend yield?

Nuvectis Pharma does not currently have a dividend yield.

Nuvectis Pharma

Nuvectis Pharma Financials at a Glance

NVCT News

Nuvectis (NVCT) Q2 Loss Widens 43%

NVCT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nuvectis Pharma

NVCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nuvectis Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NVCT

What is the current price of Nuvectis Pharma?

What is the 52-week range for Nuvectis Pharma?

How much debt does Nuvectis Pharma have?

How much cash does Nuvectis Pharma have on hand?

What is Nuvectis Pharma’s dividend yield?

Premium Investing Services